BioRem (BRM) Stock Overview
A clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
BRM Community Fair Values
Create NarrativeSee what 13 others think this stock is worth. Follow their fair value or set your own to get alerts.
BioRem Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$2.25 |
| 52 Week High | CA$3.45 |
| 52 Week Low | CA$1.67 |
| Beta | 0.49 |
| 1 Month Change | 13.07% |
| 3 Month Change | 0.90% |
| 1 Year Change | -24.75% |
| 3 Year Change | 167.86% |
| 5 Year Change | 435.71% |
| Change since IPO | -34.78% |
Recent News & Updates
BioRem's (CVE:BRM) Soft Earnings Don't Show The Whole Picture
Sep 01
Market Cool On BioRem Inc.'s (CVE:BRM) Earnings
May 30Recent updates
BioRem's (CVE:BRM) Soft Earnings Don't Show The Whole Picture
Sep 01Market Cool On BioRem Inc.'s (CVE:BRM) Earnings
May 30Is BioRem (CVE:BRM) Using Too Much Debt?
Feb 13Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)
Oct 11Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)
Apr 19BioRem Inc. (CVE:BRM) Soars 35% But It's A Story Of Risk Vs Reward
Apr 12BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet
Jan 25Is BioRem (CVE:BRM) Using Too Much Debt?
Aug 26Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly
Mar 23BioRem (CVE:BRM) Could Easily Take On More Debt
Aug 25These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well
May 20Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital
Jan 26Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque
Nov 23
Shareholder Returns
| BRM | CA Commercial Services | CA Market | |
|---|---|---|---|
| 7D | 0.9% | 2.1% | -0.1% |
| 1Y | -24.7% | 5.2% | 17.0% |
Return vs Industry: BRM underperformed the Canadian Commercial Services industry which returned 7% over the past year.
Return vs Market: BRM underperformed the Canadian Market which returned 16.7% over the past year.
Price Volatility
| BRM volatility | |
|---|---|
| BRM Average Weekly Movement | 6.0% |
| Commercial Services Industry Average Movement | 5.6% |
| Market Average Movement | 9.9% |
| 10% most volatile stocks in CA Market | 19.5% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: BRM has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: BRM's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | n/a | Derek Webb | www.biorem.biz |
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It also sells biofiltration media products under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK names.
BioRem Inc. Fundamentals Summary
| BRM fundamental statistics | |
|---|---|
| Market cap | CA$35.96m |
| Earnings (TTM) | CA$2.11m |
| Revenue (TTM) | CA$34.73m |
Is BRM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BRM income statement (TTM) | |
|---|---|
| Revenue | CA$34.73m |
| Cost of Revenue | CA$26.31m |
| Gross Profit | CA$8.42m |
| Other Expenses | CA$6.31m |
| Earnings | CA$2.11m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 24.25% |
| Net Profit Margin | 6.08% |
| Debt/Equity Ratio | 16.4% |
How did BRM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/24 17:54 |
| End of Day Share Price | 2025/11/21 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BioRem Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nicholas Boychuk | Cormark Securities Inc. |